Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies(303 views) Perani D, Iaccarino L, Jacobs AH, Lammertsma AA, Nordberg A, Windhorst AD, Gerhard A, Winkeler A, Jacobs AH, Gee A, Kuhnast B, Halldin C, Perani D, Brooks D, Rodriguez-vieitez E, Turkheimer FE, López-picón F, Knudsen GM, Vercouillie J, Rinne JO, Herholz K, Van Laere K, Santiago-ribeiro MJ, Herth MM, Carroll MA, Bottlaender M, Hansson O, Edison P, Hinz R, Boellaard R, Moresco RM, Pappata S
Keywords: Amyloid, Neuroinflammation, Pet Molecular Imaging, Protheinopathies, Radiotracers,
Affiliations: *** IBB - CNR ***
Vita-Salute San Raffaele University, Milan, Italy., In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy., Nuclear Medicine Unit, San Raffaele Hospital, Milan, Italy., European Institute for Molecular Imaging, University of Munster, Munster, Germany., Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.,
References: Not available.
Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies
Introduction: A rapid transition from a clinical-based classification to a pathology-based classification of neurodegenerative conditions, largely promoted by the increasing availability of imaging biomarkers, is emerging. The Framework for Innovative Multi-tracer molecular Brain Imaging, funded by the EU Joint Program - Neurodegenerative Disease Research 2016 "Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration," aimed at providing a roadmap for the applications of established and new molecular imaging techniques in dementia. Methods: We consider current and future implications of adopting a pathology-based framework for the use and development of positron emission tomography techniques. Results: This approach will enhance efforts to understand the multifactorial etiology of Alzheimer's disease and other dementias. Discussion: The availability of pathology biomarkers will soon transform clinical and research practice. Crucially, a comprehensive understanding of strengths and caveats of these techniques will promote an informed use to take full advantage of these tools.
Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies
No results.
Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies